Lipocine Inc (LPCN) — Cash Flow-to-Debt Ratio
Lipocine Inc (LPCN) has a Cash Flow-to-Debt Ratio of -0.89x as of March 2026, meaning its operating cash flow of $-2.26 Million could theoretically repay -1% of its total liabilities ($2.53 Million) in one year. Explore Lipocine Inc (LPCN) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lipocine Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Lipocine Inc across 15 annual periods. Also explore Lipocine Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Lipocine Inc (2011–2025)
Year-by-year debt coverage analysis for Lipocine Inc. For market capitalisation and broader financial context, see Lipocine Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.86x | $-9.76 Million | $2.53 Million | ▼ -378.3% |
| 2024 | -0.81x | $-1.22 Million | $1.51 Million | ▲ +82.1% |
| 2023 | -4.51x | $-11.87 Million | $2.63 Million | ▲ +28.1% |
| 2022 | -6.27x | $-11.97 Million | $1.91 Million | ▼ -883.0% |
| 2021 | -0.64x | $-4.41 Million | $6.91 Million | ▲ +58.3% |
| 2020 | -1.53x | $-15.30 Million | $10.01 Million | ▼ -75.2% |
| 2019 | -0.87x | $-11.67 Million | $13.37 Million | ▲ +17.5% |
| 2018 | -1.06x | $-12.08 Million | $11.42 Million | ▲ +59.8% |
| 2017 | -2.63x | $-16.70 Million | $6.35 Million | ▲ +80.9% |
| 2016 | -13.79x | $-18.28 Million | $1.33 Million | ▼ -204.5% |
| 2015 | -4.53x | $-15.36 Million | $3.39 Million | ▲ +57.3% |
| 2014 | -10.59x | $-17.30 Million | $1.63 Million | ▼ -58.3% |
| 2013 | -6.69x | $-8.59 Million | $1.28 Million | ▼ -26.6% |
| 2012 | -5.29x | $-62.87K | $11.89K | ▼ -451.1% |
| 2011 | -0.96x | $-7.29K | $7.61K | — |